[Evaluation of the immune status of patients with dysfunctional uterine hemorrhages during treatment with female sex hormones].
D000328:Adult; D000917:Antibody Formation / Q000187:drug effects; D003277:Contraceptives, Oral, Combined / Q000627:therapeutic use; D005040:Ethynodiol Diacetate / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D008656:Mestranol / Q000627:therapeutic use*; D008875:Middle Aged; D011374:Progesterone / Q000627:therapeutic use*; D014592:Uterine Hemorrhage / Q000188:drug therapy / Q000276:immunology*
D003277:Contraceptives, Oral, Combined; D011374:Progesterone; D005040:Ethynodiol Diacetate; C018467:Bisecurin I; D008656:Mestranol
Otsenka immunnogo statusa bol'nykh s disfunktsional'nymi matochnymi krovotecheniiami pri lechenii zhenskimi polovymi gormonami.